Literature DB >> 30369366

[A review on the relationship between mitochondrial dysfunction and white matter injury in preterm infants].

Wen-Xing Li1, Yi Qu, De-Zhi Mu, Jun Tang.   

Abstract

White matter injury in preterm infants has a complex etiology and can lead to long-term neurocognitive and behavioral deficits, but there are still no specific treatment methods for this disease at present. More and more studies have shown that mitochondrial dysfunction plays an important role in the pathogenesis of white matter injury in preterm infants and might be a common subcellular mechanism of white matter developmental disorder, which involves oxidative stress, reduced ATP synthesis, and disequilibrium of calcium homeostasis. This article reviews the role of mitochondria in brain development and the mechanism of mitochondrial dysfunction, with a hope to perform early intervention of white matter injury in preterm infants by protecting mitochondrial function, so as to provide a reference for improving the neurodevelopmental outcome of preterm infants who survive.

Entities:  

Mesh:

Year:  2018        PMID: 30369366      PMCID: PMC7389051     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  42 in total

Review 1.  Limiting oxidative stress following neurotrauma with a combination of ion channel inhibitors.

Authors:  Hannah R Milbourn; Lillian M Toomey; Nikolas Gavriel; Chloe G G Gray; Alexander H Gough; Brooke Fehily; Marcus K Giacci; Melinda Fitzgerald
Journal:  Discov Med       Date:  2017-06       Impact factor: 2.970

2.  Effect of ATP depletion on the palmitoylation of myelin proteolipid protein in young and adult rats.

Authors:  O A Bizzozero; P Sanchez; S U Tetzloff
Journal:  J Neurochem       Date:  1999-06       Impact factor: 5.372

Review 3.  Neonatal mitochondrial leukoencephalopathy with brain and spinal involvement and high lactate: expanding the phenotype of ISCA2 gene mutations.

Authors:  Irene Toldo; Margherita Nosadini; Chiara Boscardin; Giacomo Talenti; Renzo Manara; Eleonora Lamantea; Andrea Legati; Daniele Ghezzi; Giorgio Perilongo; Stefano Sartori
Journal:  Metab Brain Dis       Date:  2018-01-23       Impact factor: 3.584

4.  Reactive species and oxidative stress in optic nerve vulnerable to secondary degeneration.

Authors:  Ryan L O'Hare Doig; Carole A Bartlett; Ghassan J Maghzal; Magdalena Lam; Michael Archer; Roland Stocker; Melinda Fitzgerald
Journal:  Exp Neurol       Date:  2014-06-12       Impact factor: 5.330

5.  Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.

Authors:  Malena B Rone; Qiao-Ling Cui; Jun Fang; Li-Chun Wang; Ji Zhang; Damla Khan; Melissa Bedard; Guillermina Almazan; Samuel K Ludwin; Russel Jones; Timothy E Kennedy; Jack P Antel
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

6.  Role of extracellular calcium and mitochondrial oxygen species in psychosine-induced oligodendrocyte cell death.

Authors:  V Voccoli; I Tonazzini; G Signore; M Caleo; M Cecchini
Journal:  Cell Death Dis       Date:  2014-11-20       Impact factor: 8.469

Review 7.  A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease.

Authors:  Estela Area-Gomez; Ad de Groof; Eduardo Bonilla; Jorge Montesinos; Kurenai Tanji; Istvan Boldogh; Liza Pon; Eric A Schon
Journal:  Cell Death Dis       Date:  2018-02-28       Impact factor: 8.469

8.  Bax inhibitor-1-mediated inhibition of mitochondrial Ca2+ intake regulates mitochondrial permeability transition pore opening and cell death.

Authors:  Geum-Hwa Lee; Hwa-Young Lee; Bo Li; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Sci Rep       Date:  2014-06-05       Impact factor: 4.379

9.  A mitochondrial division inhibitor, Mdivi-1, inhibits mitochondrial fragmentation and attenuates kainic acid-induced hippocampal cell death.

Authors:  Hwajin Kim; Jong Youl Lee; Keon Jae Park; Won-Ho Kim; Gu Seob Roh
Journal:  BMC Neurosci       Date:  2016-06-10       Impact factor: 3.288

Review 10.  Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis.

Authors:  Rebecca M Heidker; Mitchell R Emerson; Steven M LeVine
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.